• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL CANADA, INC. TRIFECTA VALVE,IDE,25MM; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL CANADA, INC. TRIFECTA VALVE,IDE,25MM; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-25A-IDE
Device Problems Gradient Increase (1270); Therapeutic or Diagnostic Output Failure (3023)
Patient Problems Calcium Deposits/Calcification (1758); Stenosis (2263)
Event Date 02/10/2016
Event Type  Injury  
Manufacturer Narrative
Gtin number: unknown.
 
Event Description
This 25 mm sjm trifecta valve was implanted on (b)(6) 2008.On (b)(6) 2016, calcification, stenosis and an elevated mean gradient were noted via echocardiogram.The valve was explanted on (b)(6) 2016 and replaced with a 27 mm magna ease valve.The patient is reported to be stable.
 
Manufacturer Narrative
(b)(4).The results of this investigation concluded there was fibrous pannus ingrowth on the inflow surface of all thee cusps, narrowing the inflow diameter.Cusp 3 was fibrotically thickened, and all three cusps contained calcifications.A thin layer of fibrin was observed on the outflow surface of cusp 2.No acute inflammation was observed and gram stains were negative for organisms.No evidence was found to suggest the cause of the fibrin, calcification, and pannus was due to an intrinsic defect in the valve, as supported by review of the valve's device history record and the analysis performed.The cause of the reported event remains unknown.
 
Event Description
This 25 mm sjm trifecta valve was implanted on (b)(6) 2008.On (b)(6) 2016, calcification, stenosis and an elevated mean gradient were noted via echocardiogram.The maximum transaortic pressure gradient was 55 mm hg and the average transaortic pressure gradient was 29 mm hg.The valve was explanted on (b)(6) 2016 and replaced with a 27 mm magna ease valve.The patient is reported to be stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA VALVE,IDE,25MM
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL CANADA, INC.
2550 blvd. vanier
st. hyacinthe J2S 6 L7
CA  J2S 6L7
Manufacturer (Section G)
ST. JUDE MEDICAL CANADA, INC.
2550 blvd. vanier
st. hyacinthe J2S 6 L7
CA   J2S 6L7
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key5474106
MDR Text Key39469722
Report Number8020430-2016-00002
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeCA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/10/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/02/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTF-25A-IDE
Device Catalogue NumberTF-25A-IDE
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/25/2016
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/11/2016
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age74 YR
Patient Weight95
-
-